← Leaderboards
Kelley N Cooper
University Of Louisville
$69,432
Attributed
$69,432
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $35.2K · FY2022–23$50K$37.5K$25K$12.5K$0
'22
'23
Funding mix
By agency
NIH$69,432 · 1
By mechanism
F31$69,432 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Louisville
Same institution · by research overlap
- David A Scott$7,766,423
- Silvia M Uriarte$8,211,635
- Huizhi Wang$3,892,237
- Denis F Kinane$2,904,266
- Fata Moradali$1,785,737
Others in their field
Other Rising Stars on “Anti-Inflammatory Agents”
- Sabrina Paganoni · Massachusetts General Hospital$11,004,714
- Suma Babu · Massachusetts General Hospital$11,004,714
- David Jackson · Ceria Therapeutics, Inc.$4,663,387
- Claudia Martinez · University Of Miami School Of Medicine$3,345,252
- Amar Nijagal · University Of California, San Francisco$3,176,680
- Alireza Hassani Najafabadi · Terasaki Institute For Biomedical Innovation$3,065,252
Research focus
Anti-Inflammatory AgentsApoptosisApoptoticAreaAutoimmune DiseasesAutoinflammatoryBacterial InfectionsBindingBypassCareerCell PhysiologyCellsChronicChronic InfectionCreb1 GeneCyclic AmpCyclic Amp-Dependent Protein KinasesCytokineDefectDegradation PathwayDesignDigestionExcisionAbate
Grant awards (2)
Mechanisms and Immune consequences of atypical efferocytosis of neutrophils during Porphyromonas gingivalis infection.$35,227
F31 · FY2023 · DE · contact PI
Mechanisms and Immune consequences of atypical efferocytosis of neutrophils during Porphyromonas gingivalis infection.$34,205
F31 · FY2022 · DE · contact PI